The University of Chicago Header Logo

Connection

Alexis Demonbreun to Muscular Dystrophies

This is a "connection" page, showing publications Alexis Demonbreun has written about Muscular Dystrophies.
Connection Strength

1.949
  1. Anti-latent TGFß binding protein 4 antibody improves muscle function and reduces muscle fibrosis in muscular dystrophy. Sci Transl Med. 2021 Sep 08; 13(610):eabf0376.
    View in: PubMed
    Score: 0.708
  2. Dysferlin and myoferlin regulate transverse tubule formation and glycerol sensitivity. Am J Pathol. 2014 Jan; 184(1):248-59.
    View in: PubMed
    Score: 0.411
  3. Impaired muscle growth and response to insulin-like growth factor 1 in dysferlin-mediated muscular dystrophy. Hum Mol Genet. 2011 Feb 15; 20(4):779-89.
    View in: PubMed
    Score: 0.336
  4. The super-healing MRL strain promotes muscle growth in muscular dystrophy through a regenerative extracellular matrix. JCI Insight. 2024 01 04; 9(3).
    View in: PubMed
    Score: 0.208
  5. Loss of dysferlin or myoferlin results in differential defects in excitation-contraction coupling in mouse skeletal muscle. Sci Rep. 2021 08 05; 11(1):15865.
    View in: PubMed
    Score: 0.176
  6. Genetic background influences muscular dystrophy. Neuromuscul Disord. 2005 Oct; 15(9-10):601-9.
    View in: PubMed
    Score: 0.059
  7. The extracellular matrix differentially directs myoblast motility and differentiation in distinct forms of muscular dystrophy: Dystrophic matrices alter myoblast motility. Matrix Biol. 2024 May; 129:44-58.
    View in: PubMed
    Score: 0.053
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.